A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens

NCT04152915 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide

Sponsor

Novo Nordisk A/S